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Abstract
Photoacoustic tomography (PAT) is a molecular imaging technology. Unlike conventional reporter gene imaging, which is
usually based on fluorescence, photoacoustic reporter gene imaging relies only on optical absorption. This work
demonstrates several key merits of PAT using lacZ, one of the most widely used reporter genes in biology. We show that the
expression of lacZ can be imaged by PAT as deep as 5.0 cm in biological tissue, with resolutions of ,1.0 mm and ,0.4 mm
in the lateral and axial directions, respectively. We further demonstrate non-invasive, simultaneous imaging of a lacZ-
expressing tumor and its surrounding microvasculature in vivo by dual-wavelength acoustic-resolution photoacoustic
microscopy (AR-PAM), with a lateral resolution of 45 mm and an axial resolution of 15 mm. Finally, using optical-resolution
photoacoustic microscopy (OR-PAM), we show intra-cellular localization of lacZ expression, with a lateral resolution of
a fraction of a micron. These results suggest that PAT is a complementary tool to conventional optical fluorescence imaging
of reporter genes for linking biological studies from the microscopic to the macroscopic scales.
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Introduction
A key finding of the Human Genome Project, completed in
2003, was that in our enormous genome of 20,000–25,000 genes,
only 2% of the total encodes all of the proteins necessary for
building the human body and executing its physiological functions
[1]. We are now being challenged to identify the functions of the
discovered genes, understand the molecular mechanisms of
physiology and pathology, and develop personalized treatment
of diseases [2]. These investigations require evaluating the
expression patterns of the genes of interest. Traditional methods
that measure mRNA in vitro have several limitations. First, in vitro
observation may not correspond to what occurs in vivo due to the
difficulty of replicating the native microenvironment. Second, they
produce only a single data point from each cell culture or
sacrificed animal. To get statistically robust data, procedures must
be repeated many times, which is labor-intensive, time-consuming,
and costly. Third, they are incapable of localizing where genes are
expressed in cells. Fourth, due to the various translational and
post-translational modifications of the gene products, the level of
mRNA for a gene may not quantitatively correlate with the
protein production of the same gene [3].
With the promise of overcoming these limitations, molecular
imaging is rapidly being developed for interrogating gene
expression in vivo [4,5,6], which allows visualization of the
spatiotemporal distribution of gene expression in the native
environment. The non-invasive nature of molecular imaging
allows for the animals studied to serve as their own controls in
a longitudinal study, minimizing the uncertainty caused by inter-
sample variability. Thus, molecular imaging greatly reduces
animal use, labor, and cost. Moreover, molecular imaging could
deeply impact clinical practices by contributing to the early
detection and fast staging of diseases, accurate evaluation of
treatment outcomes, and rational design of novel therapies.
Two optical imaging tools, bioluminescence imaging (BLI) and
fluorescence imaging (FLI), are currently the main techniques used
in preclinical research to study gene expression. BLI can detect fM
of protein while FLI has a typical sensitivity on the order of nM
[5]. Both methods have high throughput rates, however they have
limited imaging depth (,1 cm) [5], lack of depth resolution, and
PLOS ONE | www.plosone.org 1 August 2012 | Volume 7 | Issue 8 | e43999
poor lateral resolution. Although mm-order resolution is achiev-
able optically within a thin slide of tissue, deeper structures are
poorly resolved in vivo due to optical diffusion.
None of the current mainstream molecular imaging modalities
can visualize gene expression at both microscopic and macro-
scopic levels. Previous works have suggested a new approach to
imaging gene expression in vivo using photoacoustic tomography
(PAT) based on optical absorption [7,8,9]. In our previous work,
a single-scale single2/dual-wavelength photoacoustic system was
used to non-invasively and simultaneously image the morphology
of a lacZ-marked 9 L gliosarcoma and its surrounding microvas-
culature in vivo [7,8]. Different implementations of PAT allow the
spatial resolution to be scaled with the desired imaging depth while
maintaining a high depth-to-resolution ratio, which emphasizes
the unique multi-scale, high-resolution imaging capability of PAT
in this paper [10,11,12]. In this work, we demonstrate that PAT
can create multi-scale images of gene expression in living
biological structures. We show dual-wavelength photoacoustic
images with improved image quality and three-dimensional (3D)
depiction of the tumor and surrounding vessels. We explore how
deep in tissue PAT can detect lacZ expression, and also show intra-
cellular localization of lacZ expression with a sub-micron lateral
resolution. The results indicate that PAT can bridge the gap
between the microscopic and macroscopic domains in molecular
biology studies.
Materials and Methods
Chromogenic lacZ Reporter Gene System
Although developed earlier, chromogenic reporter genes have
been much neglected for molecular imaging, largely due to the
lack of tools to visualize their expression inside living organisms.
PAT remedies this and, in our opinion, will rejuvenate the
development of new in vivo chromogenic reporter gene systems to
solve current challenges in biological imaging.
In this study, we selected the lacZ gene, one of the most widely
used chromogenic reporter genes, for multiscale PAT. Originating
from E. Coli, lacZ encodes b-galactosidase, a bacterial enzyme
responsible for metabolizing lactose into glucose and galactose.
The expression of lacZ can be studied by several chromogenic
assays. Among them, we chose to use 5-bromo-4-chloro-3-indolyl-
b-D-galactoside (X-gal) as our in vivo molecular probe. X-gal is
a colorless analogue of lactose, in which the glucose fragment is
replaced by an indole-derivative. b-galactosidase cleaves the
glycosidic linkage in X-gal and yields galactose and an optical
transparent indoxyl monomer, 5-bromo-4-chloro-3-hydroxyin-
dole. Afterwards, two of the monomers are oxidized to form
a stable insoluble blue product, 5,59-dibromo-4,49-dichloro-indigo
[Figure 1(a)] [13]. Figure 1(b) shows the dramatic chromogenic
color change 24 hours after addition of 20 mg/ml X-gal solution
to the native cell lysate of transgenic 9 L gliosarcoma cells
expressing the lacZ reporter gene. There are other colorimetric
assays for b-galactosidase activity, such as o-nitrophenyl-b-D-
galactoside (ONPG). However, the blue product from X-gal
absorbs light strongly between 605 and 665 nm [8] which is
located in the so-called ‘‘optical diagnostic window’’, and allows us
to detect the expression of lacZ at great depths in tissue.
For in vivo imaging, the lacZ/X-gal reporter gene system has two
noticeable advantages. First, X-gal is an activatable probe. X-gal
alone is colorless. Strong optical absorption is generated only after
it is cleaved by b-galactosidase. Thus, clearance of the un-cleaved
X-gal before imaging is not required. As a result, the activity of b-
galactosidase can be measured by PAT against a minimal
background. Second, this enzymatic reporter system possesses an
intrinsic signal-amplification mechanism. As an enzyme, a single
b-galactosidase molecule can cleave multiple X-gal molecules to
produce a large number of blue product molecules, allowing us to
detect a low expression level of lacZ.
Cell Culture
A wild-type 9 L gliosarcoma cell line was provided by Dr.
Michael Welch’s laboratory in the School of Medicine of
Washington University in St. Louis (Commercial source: ATCC,
Manassas, VA). The 9 L/lacZ cell line was created by transfecting
the 9 L cell with BAG replication deficient retroviral vector
carrying the E. Coli lacZ gene. The 9 L/lacZ cells were purchased
from American Type Culture Center (Manassas, VA). The cells
were cultured in Dulbecco’s Modified Eagle Medium (DMEM,
Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine
serum (FBS, Invitrogen) and 1 mM sodium pyruvate (Invitrogen).
Preparation of the Native Cell Lysate
After removal of the culture medium, the 9 L/lacZ cells were
rinsed with phosphate-buffered saline (PBS, Invitrogen) and then
collected into a 15 ml centrifuge tube. The cells were harvested
after centrifuging at 4uC for 5 minutes and discarding the
supernatant. Then we mixed ice-cold RIPA lysis buffer (Sigma-
Aldrich, St. Louis, MO) with the cells and incubated them in ice
for 40 minutes. During the incubation, the solution was re-
suspended every 10 minutes. Finally, the solution was centrifuged
for 20 minutes at 4uC. The supernatant, containing the active
natively expressed b-galactosidase, was collected as the lysate of
9 L/lacZ cells.
Animal Preparation for Imaging
This animal study was approved by the Washington University
in St. Louis Animal Studies Committee. For tumor inoculation,
a 5-ml PBS suspension containing 5 million wild-type 9 L or 9 L/
lacZ cells was subcutaneously injected into anaesthetized mice
(Hsd:Athymic Nude-FoxnlNU, Harlan) using a 0.3-ml syringe
with a 29-gauge needle. Tumors were left to grow and monitored
daily. Imaging was performed after the progression of the tumor
became obvious. Hair was removed before imaging. For detecting
the expression of lacZ,,0.4 mg of X-gal in 20 ml PBS and DMSO
(1:1) was injected near the tumor 1 day before imaging. During
imaging, the animals were was maintained under anesthesia by
a gas mixture of oxygen and 1% isoflurane flowing at a rate of
1 L/min, and their blood oxygenation and heart rates were closely
monitored. All mice recovered naturally after the experiments
without photodamage.
Macroscopic Photoacoustic Imaging [14]
This system is capable of performing both photoacoustic and
ultrasonic imaging of the same sample. The photoacoustic signal
was excited by 6.5-ns laser pulses generated at a 10-Hz repetition
rate and a wavelength of 650 nm by a tunable dye laser
(PrecisionScan-P, Sirah) pumped by a Q-switched Nd:YAG laser
(PRO-350-10, Newport). Light fluence on the tissue surface was
measured to be ,2 mJ/cm2, 10 times lower than the ANSI safety
limit (20 mJ/cm2). The acoustic signal was detected by a 128-
element linear ultrasonic array with a nominal bandwidth of 4–
8 MHz (L8-4, Philips Healthcare). The imaging probe was
scanned along the elevational direction to obtain a volumetric
image. For each 2D frame of the photoacoustic image, measure-
ments were averaged for 100 times, requiring an acquisition time
of 10 s. Photoacoustic images were reconstructed using a Fourier-
domain beam-forming algorithm [15]. The in-plane resolutions of
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PLOS ONE | www.plosone.org 2 August 2012 | Volume 7 | Issue 8 | e43999
this system are ,1.0 mm and ,0.4 mm in the lateral and axial
directions, respectively, at 5 cm deep in biological tissue [16].
Acoustic-resolution Photoacoustic Microscopy (AR-PAM)
[8,17]
A tunable dye laser (CBR-D, Sirah), pumped by a Nd:YLF laser
(INNOSLAB, Edgewave), provided laser pulses at two wave-
lengths, 584 nm and 635 nm. The pulse width was 7 ns, and the
maximum repetition rate was ,5 kHz. The light focus coaxially
overlapped with the focus of a high-frequency ultrasonic trans-
ducer (V214-BB-RM, Olympus NDT. Central frequency:
50 MHz). The incident energy density at the tissue surface was
controlled to be below 6 mJ/cm2. A mechanical stage drove the
raster scanning of the imaging probe to obtain a volumetric
dataset without averaging. The maximum photoacoustic ampli-
tudes along each axial line were projected onto the skin surface to
form a maximum-amplitude projection (MAP) image. The current
system was quantified to have a lateral resolution of 45 mm and an
axial resolution of 15 mm, and was capable of imaging ,3 mm
deep into the skin [17].
Optical-resolution Photoacoustic Microscopy (OR-PAM)
[18]
For photoacoustic excitation, a compact diode-pumped
Nd:YVO4 laser (SPOT 100–532, Elforlight, UK. Maximal pulse
repetition rate: 50 kHz) generated 1.2-ns pulses at a wavelength of
532 nm. The light was delivered by a single-mode optical fiber
and focused into a diffraction-limited spot inside the tissue. The
generated photoacoustic signal was detected by an ultrasonic
transducer (Central frequency: 40 MHz; NA: 0.5) in transmission
mode. The scanning mode was the same as AR-PAM and could
also form an MAP image after scanning. The lateral resolution of
this set-up was quantified to be 0.40 mm [18].
Results
Macroscopic Photoacoustic Imaging
Figure 2(a) shows a photograph of a tumor-bearing nude mouse
before imaging. 9 L tumors with and without lacZ transgene were
grown in its right and left flanks, respectively. Both tumors were
injected with the same amount of X-gal before imaging. Once the
mouse was sacrificed after imaging, we removed the skin on top of
Figure 1. Detecting the expression of the lacZ reporter gene using the chromogenic X-gal probe. (a) The hydrolysis of X-Gal catalyzed by
b-galactosidase. (b) Photographs showing the chromogenic change after addition of X-gal solution into the native lysate of 9 L/lacZ cells.
doi:10.1371/journal.pone.0043999.g001
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the tumors, and found only the lacZ + tumor was stained blue,
which further confirms the specificity of the detection of the lacZ
expression by the chromogenic X-gal probe [Figure 2(b)]. The
tumor-bearing region of the mouse was imaged in vivo with both
photoacoustic and ultrasonic imaging. Figures 2(c–e) show the
composite dual-modality images in volumetric visualization,
a cross-sectional view, and projection view, respectively. Therein,
photoacoustic images are colored green, while ultrasonic images
are colored in gray scale. Figure 2(c) shows we could localize the
lacZ + tumor in three dimensions. Also, we observed that although
the tumor showed as a hypoechoic area in ultrasonic images, the
lack of ultrasonic scattering was not a specific indicator for tumor
[Figure 2(d)]. In contrast, using the lacZ/X-gal reporter strategy,
PAT could detect the lacZ-marked tumor with a high specificity
[Figure 2(e)]. Moreover, by overlaying chicken breast tissue on top
of the tumor, we found the expression of lacZ remained visible at
a depth of 5.0 cm in biological tissue, with a contrast of 3.04.
Acoustic-resolution Photoacoustic Microscopy
Blood vessels and the blue product have well-separated
absorption peaks, and can be separately visualized by PAT at
different optical wavelengths (Figure 3). Two wavelengths (584 nm
and 635 nm) were selected to maximize the difference between the
optical absorption of hemoglobin and the blue product within the
efficient emission band of the DCM laser dye. While the 635-nm
wavelength was selected to map the lacZ-marked tumor
[Figure 3(a)], the 584-nm wavelength was used to visualize the
microvasculature [Figure 3(b)]. The photoacoustic signal in
Figure 3(b) represents the relative value of total hemoglobin
concentration. A combined image [Figure 3(c) and 3(d)] shows the
spatial relation between the tumor and the surrounding micro-
vasculature.
Optical-resolution Photoacoustic Microscopy
Figure 4(a) shows photoacoustic images of fixed 9 L/lacZ cells
grown on a cover glass after staining in 1 mg/ml X-gal solution at
37uC for 12 hours. Figure 4(b) shows a micrograph of fixed 9 L/
lacZ cells using a Nanozoomer 2.0-HT slide scanner (Hamamatsu,
Hamamatsu City, Japan). We observed that 9 L/lacZ cells were
between 20 and 40 mm in diameter. Inside the cells, strong
absorbers were scattered around low-absorbing centers that are
cell nuclei (nu, indicated by arrow). This finding implies that b-
galactosidase, the final product of lacZ expression, exists mostly in
the cytoplasm.
Discussion
Using the macroscopic photoacoustic system, we imaged the
expression of lacZ at a depth of 5.0 cm in biological tissue. This
demonstrated the advantage of PAT over other optical molecular
imaging techniques, such as BLI and FLI, in penetration depth. In
addition, all images were obtained by averaging over 100
measurements, but using a low optical energy at 1/10 of the
ANSI exposure limit. Assuming noise was uncorrelated between
Figure 2. Imaging 9 L tumors with and without the lacZ reporter gene by an array-based photoacoustic and ultrasonic imaging
system in vivo. (a) Photograph of a tumor-bearing mouse before imaging. (b) Post-euthanasia photograph of the lacZ- and lacZ+ tumors after
removing the skin above. (c, d, e) Composite photoacoustic and ultrasonic images shown in (c) three-dimensional visualization, (d) a typical B-scan,
and (e) the maximum amplitude projection view on the skin. (f) B-scan image of the lacZ-marked tumor at a 5-cm depth in biological tissue, acquired
by overlaying chicken breast tissue on top of a mouse. Photoacoustic images are colored green, while ultrasonic images are in gray. The scale bars
represent 5 mm.
doi:10.1371/journal.pone.0043999.g002
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measurements, we could potentially obtain images with the same
quality at a speed of 10 frames/second while using the maximum
laser energy allowed by the ANSI standard. The imaging speed
can be further improved by adopting a high-repetition rate laser.
We further demonstrated simultaneous imaging of a lacZ-
marked tumor and its surrounding microvasculature by dual-
wavelength AR-PAM. Remodeling of the microcirculation plays
an important role in oncology. Although photoacoustic computed
tomography is able to detect the lacZ-marked tumor at great
depth, it lacks the resolving power to visualize the microcirculation
system associated with the tumor. AR-PAM uses a high-frequency
focused transducer, and can achieve sufficient resolving power to
visualize the microvasculature at the cost of imaging depth.
It is noted that the reaction product of X-gal is almost insoluble
in water and is thus difficult to be cleared by the body. However,
by using other galactopyranosides (e.g., chlorophenolred-b-D-
galactopyranoside (CPRG) and ortho-Nitrophenyl-b-galactoside
(ONPG)) whose cleavage products by b-galactosidase are water-
soluble, chronic monitoring of gene expression in a single sample
at multiple time points can be achieved.
We showed the sub-cellular localization of the lacZ expression
using OR-PAM. By confining photoacoustic excitation by tight
optical focusing, OR-PAM has been proven to obtain a lateral
resolution of a fraction of a micron [18], and could potentially
play an important role in studying molecular biology in cultured
cells.
Currently, each of the imaging systems is independent, which
means one PAT system achieves only one specific resolution.
Thus, a single PAT system with switchable resolutions and
penetration depths is of great interest. To integrate a macroscopic
photoacoustic imaging system with AR-PAM, we simply need to
replace the 50-MHz transducer in AR-PAM with a lower
frequency transducer and adjust the laser exposure accordingly.
Previous work has demonstrated that an AR-PAM with a 5-MHz
transducer provides penetration up to 38 mm in chicken breast
tissue. At the 19-mm depth, the axial resolution is 144 mm and the
lateral resolution is 560 mm [19]. To integrate AR-PAM with OR-
PAM, the laser output can be split into two beams, and a fiber
bundle can be used to switch illuminations for AR-PAM and OR-
PAM. A single core of the fiber bundle can deliver light for OR-
PAM with high lateral resolution, while all cores of the fiber
bundle can illuminate a larger area for AR-PAM. An integrated
AR-PAM and OR-PAM system is under construction by our
group.
In summary, we demonstrated several key merits of PAT as
a promising candidate for molecular imaging. We proved that the
expression of lacZ can be detected by PAT as deep as 5.0 cm in
biological tissue. In addition, we showed that PAT could follow the
Figure 3. Simultaneously imaging a lacZ-marked tumor and its associated microvasculature by dual-wavelength AR-PAM in vivo. (a)
MAP mage acquired at 635 nm showing tumor morphology. (b) MAP image acquired at 584 nm showing microvasculature. (c) Composite image
showing the spatial relations between tumor and blood vessels. (d) 3D depiction of composite PA image showing the tumor and blood vessels (Video
S1, MPEG, 5.75 MB). Green: tumor. Arrows indicate feeding vessels of the tumor. The scale bars represent 2 mm.
doi:10.1371/journal.pone.0043999.g003
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gene expression at scalable depths and resolutions. We expect that
PAT could become an important tool linking biological studies at
the microscopic and macroscopic levels. With the future de-
velopment of new chromogenic reporter gene systems, photo-
acoustic reporter gene imaging can impact both laboratory
research and clinical practice.
Supporting Information
Video S1 3D depiction of composite AR-PAM image
acquired at 635 nm and 584 nm showing the tumor and
blood vessels. Green: tumor. Red: microvasculature.
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